# FDA Inspection 987227 - Regenerative Biologics, Inc. - August 09, 2016

Source: https://www.globalkeysolutions.net/records/fda_inspections/regenerative-biologics-inc/378cc031-e9b3-4833-a394-8585eae96e25
Source feed: FDA_Inspections

> FDA Inspection 987227 for Regenerative Biologics, Inc. on August 09, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 987227
- Company Name: Regenerative Biologics, Inc.
- Inspection Date: 2016-08-09
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1101140 - 2019-07-12](https://www.globalkeysolutions.net/records/fda_inspections/regenerative-biologics-inc/fe5fdd4a-3b79-471c-b31d-48e9e3925168)
- [FDA Inspection 1101140 - 2019-07-12](https://www.globalkeysolutions.net/records/fda_inspections/regenerative-biologics-inc/fc2f7e66-5cfc-4018-8c4c-4e7ea38600cd)

Company: https://www.globalkeysolutions.net/companies/regenerative-biologics-inc/b934cc74-d5de-4970-b4a2-dc9f4636cacc

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d